1.Differences in major adverse cardiovascular events of metabolic dysfunction-associated steatotic liver disease by race and ethnicity: Letter to the editor on “Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and ethnicity: A longitudinal real-world study”
Hui-Chin CHANG ; Wen-Chieh LIAO ; Yi-Jen FANG ; Shiu-Jau CHEN ; Shuo-Yan GAU
Clinical and Molecular Hepatology 2024;30(4):978-981
2.Differences in major adverse cardiovascular events of metabolic dysfunction-associated steatotic liver disease by race and ethnicity: Letter to the editor on “Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and ethnicity: A longitudinal real-world study”
Hui-Chin CHANG ; Wen-Chieh LIAO ; Yi-Jen FANG ; Shiu-Jau CHEN ; Shuo-Yan GAU
Clinical and Molecular Hepatology 2024;30(4):978-981
3.Differences in major adverse cardiovascular events of metabolic dysfunction-associated steatotic liver disease by race and ethnicity: Letter to the editor on “Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and ethnicity: A longitudinal real-world study”
Hui-Chin CHANG ; Wen-Chieh LIAO ; Yi-Jen FANG ; Shiu-Jau CHEN ; Shuo-Yan GAU
Clinical and Molecular Hepatology 2024;30(4):978-981
4.Differences in major adverse cardiovascular events of metabolic dysfunction-associated steatotic liver disease by race and ethnicity: Letter to the editor on “Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and ethnicity: A longitudinal real-world study”
Hui-Chin CHANG ; Wen-Chieh LIAO ; Yi-Jen FANG ; Shiu-Jau CHEN ; Shuo-Yan GAU
Clinical and Molecular Hepatology 2024;30(4):978-981